Trial intelligence / Profile preview

Chloroprocaine vs ropivacaine for breakthrough pain during labor epidural analgesia

ChiCTR2000041461Phase 4Recruiting

Sponsor
Anhui Province Maternity and Child Health Hospital
Start
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of chloroprocaine in Breakthrough pain during labor analgesia (BTP) (2 arms), sponsored by Anhui Province Maternity and Child Health Hospital. Primary endpoints: Time to VAS score ≤3 after rescue dose and Maternal satisfaction score. Started Feb 2021; status: recruiting.

02

Drugs

chloroprocaine
03

Conditions

Breakthrough pain during labor analgesia (BTP)

Beyond the preview

Go deeper on ChiCTR2000041461.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000041461.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call